International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 10.29.2020
three researchers with mask
two doctors doing research
Science Leads the Way in the Treatment of Myeloma and COVID-19
With the publication of the International Myeloma Working Group’s new method for identifying smoldering myeloma patients who should be treated and some good news about COVID-19 treatments and vaccines, science is leading the way, says IMF Chairman Brian G.M. Durie. And that’s a good thing.
read the blog
international myeloma working group logo
International Myeloma Working Group’s New Risk Stratification Model for Smoldering Myeloma Will Reduce Risk of Disease Progression and End-Organ Damage
The IMF’s International Myeloma Working Group, a body of the world’s top myeloma experts, has created a new way of identifying which patients with smoldering multiple myeloma (SMM) are candidates for early treatment and clinical trials. The new risk stratification model appears in the latest edition of Blood Cancer Journal.
2020LearnMoreButton.png
living well telehealth headshot
Register for This Free “Living Well with Myeloma” Webinar on Telehealth Services
Register now for FREE this “Living Well with Myeloma: Telehealth—How to Make the Most of Your Healthcare Provider Visit” Webinar on Thursday, November 12, at 4:00 p.m. PT / 7:00 p.m. ET. The speakers are Beth Faiman, PhD, RN, MSN, APRN- BC, AOCN, FAAN (Cleveland Clinic — Taussig Cancer Institute); and Matt Faiman, MD, MBA, FACP, Medical Director, Express Care Online, and Clinical Assistant Professor of Medicine (Cleveland Clinic Foundation). In this webinar, the speakers will discuss the different ways to connect using telemedicine, and provide practical tips on how to prepare for and get the most out of your virtual appointments.
register button
everybody loves raymond cast reading reunion
Thank You for Attending: Replay NOW Available
The IMF is grateful for your support this past Friday. Thousands gathered online to watch the 14th Annual Virtual Comedy Celebration, hosted by Ray Romano and featuring a cast reunion from the classic sitcom “Everybody Loves Raymond.” In case you missed it, the video is now available on demand at comedy.myeloma.org. For those who were able to give, you helped us reach our goal and your donations will benefit the Peter Boyle Research Fund and the Black Swan Research Initiative®, the IMF’s groundbreaking project aimed at finding a cure for myeloma.
2020WatchNowButton.png
charity buzz promotion
Bid on Exclusive Items at Charitybuzz and Give to the IMF
As part of our 14th Annual Virtual Comedy Celebration, the IMF is hosting an auction of amazing items on Charitybuzz. Visit the link below to bid on 2 VIP Tickets to “Real Time with Bill Maher,” a happy hour with Phil Rosenthal of “Somebody Feed Phil,” a custom outgoing voicemail from Patricia Heaton, and many, many more items. Bid now until November 5!
bid now
Pills on bills
Read This Article on “Exploring the True Cost of Multiple Myeloma”
Because of a lack of data on the true cost of multiple myeloma, this study explores “all direct and indirect healthcare economic data across different markets” in relation to care for the disease. Lead author of this publication is IMF’s Senior Vice President, Global Advocacy, Access, Policy & Research Mimi Choon-Quinones, and one of its co-authors is IMF’s Chairman of the Board Dr. Brian G.M. Durie.
2020ReadNowButton.png
Doctor Joe Mikhael in ASH
IMF’s Chief Medical Officer Dr. Joseph Mikhael Shares Lessons That He Learned from His Father
IMF Chief Medical Officer Dr. Joseph Mikhael shares in ASH Clinical News: Editor’s Corner, heartfelt lessons from his late father. In the article “Two Ears, One Mouth,” Dr. Mikhael writes “Dad wasn’t done with his words of wisdom...He said, ‘God made you with two ears and one mouth for a reason. Listen to your patients more than you talk.’” With this sentiment in mind, “Dr. Joe” explores communication strategies in the medical field.
2020ReadNowButton.png
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

Do myeloma patients who are responding well to their treatment need to track potential bone disease?
Watch Now
 
Clinical Trials
OCEAN Trial (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Watch the Replay
IMF Patient & Family Webinar

Learn More
Winter Challenge

Bid Now
Hawaiian Raffle

Click here to see all events
 

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page